Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by sah1on Apr 03, 2020 9:35am
108 Views
Post# 30875253

RE:Why LMNL is not working for COVID-19?

RE:Why LMNL is not working for COVID-19?Oh, the irony! Emergent is the CMO for Ryplazim at its Winnipeg facility. And it was from Emergent that that Lmnl bought its plasma collection centre in Winnipeg. Hyper immune immuglobins featured in the original agreement with CNBG and Prometic presentations several years ago. Sadly, all this potential has been lost since Lmnl wrote off its Ivig protein program.
<< Previous
Bullboard Posts
Next >>